⌘K

Login Start Free

Home/Filings/4/A/0001583648-25-000023

4/A//SEC Filing

Kaupinen Wes 4/A

Accession 0001583648-25-000023

CIK 0001583648other

View on SEC.gov Company Profile

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 6:25 PM ET

Size

5.8 KB

Accession

0001583648-25-000023

Insider Transaction Report

Form 4/AAmended

Period: 2025-02-05

PALVELLA THERAPEUTICS, INC.PVLA

DirectorPresident & CEO10% Owner

Transactions

Award
Non-Qualified Stock Option (right to buy)
2025-02-05+243,831→ 243,831 total
Exercise: $14.76Exp: 2035-02-05→ Common Stock (243,831 underlying)

Footnotes (1)

[F1]The stock options will vest in equal monthly tranches over 48 months

Documents

1 file

4
edgardoc.xml
PRIMARY DOCUMENT

Issuer

PALVELLA THERAPEUTICS, INC.

CIK 0001583648

Entity typeother

Related Parties

1

filerCIK 0001918142

Filing Metadata

Form type: 4/A
Filed: Feb 9, 7:00 PM ET
Accepted: Feb 10, 6:25 PM ET
Size: 5.8 KB

View on SEC.gov